These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31500466)

  • 1. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.
    Colas RA; Nhat LTH; Thuong NTT; Gómez EA; Ly L; Thanh HH; Mai NTH; Phu NH; Thwaites GE; Dalli J
    FASEB J; 2019 Nov; 33(11):13028-13039. PubMed ID: 31500466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.
    Mai NTH; Dobbs N; Phu NH; Colas RA; Thao LTP; Thuong NTT; Nghia HDT; Hanh NHH; Hang NT; Heemskerk AD; Day JN; Ly L; Thu DDA; Merson L; Kestelyn E; Wolbers M; Geskus R; Summers D; Chau NVV; Dalli J; Thwaites GE
    Elife; 2018 Feb; 7():. PubMed ID: 29482717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
    Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
    Trials; 2011 Feb; 12():25. PubMed ID: 21288325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment.
    Thuong NTT; Vinh DN; Hai HT; Thu DDA; Nhat LTH; Heemskerk D; Bang ND; Caws M; Mai NTH; Thwaites GE
    J Infect Dis; 2019 Feb; 219(6):986-995. PubMed ID: 30299487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.
    Marais S; Meintjes G; Pepper DJ; Dodd LE; Schutz C; Ismail Z; Wilkinson KA; Wilkinson RJ
    Clin Infect Dis; 2013 Feb; 56(3):450-60. PubMed ID: 23097584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.
    Thwaites GE; Macmullen-Price J; Tran TH; Pham PM; Nguyen TD; Simmons CP; White NJ; Tran TH; Summers D; Farrar JJ
    Lancet Neurol; 2007 Mar; 6(3):230-6. PubMed ID: 17303529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
    Simmons CP; Thwaites GE; Quyen NT; Chau TT; Mai PP; Dung NT; Stepniewska K; White NJ; Hien TT; Farrar J
    J Immunol; 2005 Jul; 175(1):579-90. PubMed ID: 15972695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cerebrospinal fluid cytokine expression in tuberculous meningitis patients with treatment.
    Kashyap RS; Deshpande PS; Ramteke SR; Panchbhai MS; Purohit HJ; Taori GM; Daginawala HF
    Neuroimmunomodulation; 2010; 17(5):333-9. PubMed ID: 20407285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
    Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
    FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model.
    Kumar R; Kolloli A; Singh P; Vinnard C; Kaplan G; Subbian S
    Front Cell Infect Microbiol; 2019; 9():450. PubMed ID: 32010638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does adjunctive corticosteroid and aspirin therapy improve the outcome of tuberculous meningitis?
    Misra UK; Kalita J; Sagar B; Bhoi SK
    Neurol India; 2018; 66(6):1672-1677. PubMed ID: 30504561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Epi-LXA
    Dakin SG; Colas RA; Newton J; Gwilym S; Jones N; Reid HAB; Wood S; Appleton L; Wheway K; Watkins B; Dalli J; Carr AJ
    FASEB J; 2019 Jul; 33(7):8043-8054. PubMed ID: 30916999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial.
    Maitre T; Bonnet M; Calmy A; Raberahona M; Rakotoarivelo RA; Rakotosamimanana N; Ambrosioni J; Miró JM; Debeaudrap P; Muzoora C; Davis A; Meintjes G; Wasserman S; Wilkinson R; Eholié S; Nogbou FE; Calvo-Cortes MC; Chazallon C; Machault V; Anglaret X; Bonnet F
    Trials; 2022 Nov; 23(1):928. PubMed ID: 36348453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.
    Loxton NW; Rohlwink UK; Tshavhungwe M; Dlamini L; Shey M; Enslin N; Figaji A
    PLoS One; 2021; 16(3):e0246997. PubMed ID: 33711020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NELL2 as a potential marker of outcome in the cerebrospinal fluid of patients with tuberculous meningitis: preliminary results from a single-center observational study.
    Chen J; Wu J; Luo Y; Huang N
    Eur J Med Res; 2022 Dec; 27(1):281. PubMed ID: 36494747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    Thuong NTT; Heemskerk D; Tram TTB; Thao LTP; Ramakrishnan L; Ha VTN; Bang ND; Chau TTH; Lan NH; Caws M; Dunstan SJ; Chau NVV; Wolbers M; Mai NTH; Thwaites GE
    J Infect Dis; 2017 Apr; 215(7):1020-1028. PubMed ID: 28419368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.
    Misra UK; Kalita J; Nair PP
    J Neurol Sci; 2010 Jun; 293(1-2):12-7. PubMed ID: 20421121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
    Thwaites G; Fisher M; Hemingway C; Scott G; Solomon T; Innes J;
    J Infect; 2009 Sep; 59(3):167-87. PubMed ID: 19643501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
    van der Flier M; Hoppenreijs S; van Rensburg AJ; Ruyken M; Kolk AH; Springer P; Hoepelman AI; Geelen SP; Kimpen JL; Schoeman JF
    Pediatr Infect Dis J; 2004 Jul; 23(7):608-13. PubMed ID: 15247597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis.
    Sun Q; Sha W; Xiao HP; Tian Q; Zhu H
    Am J Med Sci; 2012 Aug; 344(2):116-21. PubMed ID: 22104430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.